Endometriosis 1990. Current Treatment Approaches

Overview

Journal Drugs

Specialty Pharmacology

Date 1990 Apr 1

PMID 2190793

Citations 8

Authors

R L Barbieri

Affiliations

Soon will be listed here.

Abstract

Endometriosis is an extremely common gynaecological disease, affecting between 1 and 5% of women of reproductive age. Women with endometriosis typically present for medical care with one of more of the following problems: pelvic pain, infertility, or a large adnexal mass (an endometrioma). The primary treatment for an endometrioma is surgical. However, long term postoperative hormone therapy may be necessary to prevent new endometriomas from developing. There is no evidence that hormonal therapy of endometriosis will improve fecundability in women with endometriosis and infertility. Pelvic pain due to endometriosis can be successfully treated with hormonal agents in the majority of patients. Four basic hormonal regimens are currently available for the treatment of endometriosis: (a) danazol; (b) gonadotrophin-releasing hormone (GnRH) [luteinising hormone-releasing hormone (LHRH); gonadorelin] agonists; (c) progesterones (progestins); and (d) combined estrogens and progesterones. Randomised, controlled, clinical trials suggest that danazol and the GnRH agonists are equally effective in the treatment of endometriosis. However, the side effects caused by danazol and the GnRH agonists are markedly different. Danazol produces androgenic side effects including weight gain, hirsutism, acne, oily skin and deepening of the voice. GnRH agonists produce side effects due to hypoestrogenism, including hot flushes, osteoporosis and dry vagina. The ideal drug regimen for the treatment of endometriosis remains to be developed.

Citing Articles

Androgen Signaling in Uterine Diseases: New Insights and New Targets.

Lv M, Yu J, Huang Y, Ma J, Xiang J, Wang Y Biomolecules. 2022; 12(11).

PMID: 36358974 PMC: 9687413. DOI: 10.3390/biom12111624.

Prospects and Challenges of the Drug Delivery Systems in Endometriosis Pain Management: Experimental and Theoretical Aspects.

Toma B, Socolov R, Popa O, Socolov D, Nica I, Agop M J Immunol Res. 2021; 2021:2727174.

PMID: 34957311 PMC: 8695015. DOI: 10.1155/2021/2727174.

Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis.

Brown J, Crawford T, Allen C, Hopewell S, Prentice A Cochrane Database Syst Rev. 2017; 1:CD004753.

PMID: 28114727 PMC: 6464974. DOI: 10.1002/14651858.CD004753.pub4.

Body size and endometriosis: results from 20 years of follow-up within the Nurses' Health Study II prospective cohort.

Shah D, Correia K, Vitonis A, Missmer S Hum Reprod. 2013; 28(7):1783-92.

PMID: 23674552 PMC: 3685336. DOI: 10.1093/humrep/det120.

Pre and post operative medical therapy for endometriosis surgery.

Yap C, Furness S, Farquhar C Cochrane Database Syst Rev. 2004; (3):CD003678.

PMID: 15266496 PMC: 6984629. DOI: 10.1002/14651858.CD003678.pub2.

References

Janne O, Kauppila A, Kokko E, Lantto T, Ronnberg L, Vihko R . Estrogen and progestin receptors in endometriosis lesions: comparison with endometrial tissue. Am J Obstet Gynecol. 1981; 141(5):562-6. DOI: 10.1016/s0002-9378(15)33278-6. View

Filicori M, Flamigni C . GnRH agonists and antagonists. Current clinical status. Drugs. 1988; 35(1):63-82. DOI: 10.2165/00003495-198835010-00004. View

Henzl M, Corson S, Moghissi K, Buttram V, Berqvist C, Jacobson J . Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N Engl J Med. 1988; 318(8):485-9. DOI: 10.1056/NEJM198802253180805. View

Holt Jr J, Keller D . Danazol treatment increases serum enzyme levels. Fertil Steril. 1984; 41(1):70-4. DOI: 10.1016/s0015-0282(16)47544-8. View

Chrisp P, Goa K . Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions. Drugs. 1990; 39(4):523-51. DOI: 10.2165/00003495-199039040-00005. View

Barbieri R, Niloff J, Bast Jr R, Scaetzl E, KISTNER R, Knapp R . Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril. 1986; 45(5):630-4. DOI: 10.1016/s0015-0282(16)49333-7. View

Barbieri R, Evans S, KISTNER R . Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up. Fertil Steril. 1982; 37(6):737-46. DOI: 10.1016/s0015-0282(16)46331-4. View

Crowley Jr W, Filicori M, Spratt D, Santoro N . The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res. 1985; 41:473-531. DOI: 10.1016/b978-0-12-571141-8.50015-9. View

Barbieri R, Lee H, Ryan K . Danazol binding to rat androgen, glucocorticoid, progesterone, and estrogen receptors: correlation with biologic activity. Fertil Steril. 1979; 31(2):182-6. DOI: 10.1016/s0015-0282(16)43820-3. View

10.

Bast Jr R, Klug T, St John E, Jenison E, Niloff J, Lazarus H . A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983; 309(15):883-7. DOI: 10.1056/NEJM198310133091503. View

11.

Luciano A, TURKSOY R, Carleo J . Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. Obstet Gynecol. 1988; 72(3 Pt 1):323-7. View

12.

KISTNER R . The use of newer progestins in the treatment of endometriosis. Am J Obstet Gynecol. 1958; 75(2):264-78. DOI: 10.1016/0002-9378(58)90384-3. View

13.

Seibel M, Berger M, Weinstein F, TAYMOR M . The effectivenss of danazol on subsequent fertility in minimal endometriosis. Fertil Steril. 1982; 38(5):534-7. DOI: 10.1016/s0015-0282(16)46630-6. View

14.

Strathy J, Molgaard C, Coulam C, Melton 3rd L . Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril. 1982; 38(6):667-72. DOI: 10.1016/s0015-0282(16)46691-4. View

15.

Tamaya T, Motoyama T, OHONO Y, Ide N, Tsurusaki T, Okada H . Steroid receptor levels and histology of endometriosis and adenomyosis. Fertil Steril. 1979; 31(4):396-400. DOI: 10.1016/s0015-0282(16)43935-x. View

16.

RANNEY B . Endometriosis. 3. Complete operations. Reasons, sequelae, treatment. Am J Obstet Gynecol. 1971; 109(8):1137-44. DOI: 10.1016/0002-9378(71)90653-3. View

17.

Lindsay R, Hart D, Forrest C, Baird C . Prevention of spinal osteoporosis in oophorectomised women. Lancet. 1980; 2(8205):1151-4. DOI: 10.1016/s0140-6736(80)92592-1. View

18.

Pittaway D, Fayez J . The use of CA-125 in the diagnosis and management of endometriosis. Fertil Steril. 1986; 46(5):790-5. DOI: 10.1016/s0015-0282(16)49812-2. View

19.

Barbieri R, Ryan K . Danazol: endocrine pharmacology and therapeutic applications. Am J Obstet Gynecol. 1981; 141(4):453-63. DOI: 10.1016/0002-9378(81)90611-6. View

20.

Barbieri R, Canick J, Makris A, Todd R, Davies I, Ryan K . Danazol inhibits steroidogenesis. Fertil Steril. 1977; 28(8):809-13. View